Eli Lilly weight-loss pill now available in U.S.

Eli Lilly's weight-loss medication, Foundayo™ (orforglipron), has officially launched in the United States following recent FDA approval. This development provides a new therapeutic option for individuals seeking weight management solutions. The pill's availability signifies a major milestone for both Eli Lilly and patients managing obesity or related conditions. The company's investment in this area reflects the growing demand for effective pharmacological interventions in addressing the global health challenge of obesity. Foundayo™ is expected to become a significant product in the pharmaceutical market.